Beiersdorf's stock crashes 40% as 2026 forecast sparks investor panic
Beiersdorf AG's share price has plunged to its lowest level in years after the company issued a gloomy forecast for 2026. Investors across Germany, Austria, and Switzerland have watched the stock lose over 40 percent of its value since January. The steep decline follows a sharp sell-off triggered by disappointing earnings projections.
The stock hit a peak of €134.45 earlier this year before tumbling to around €78. This marks a dramatic reversal from its historical high of roughly €142 in early 2025. Since 2023, the share price has seen ups and downs, with a previous low of €95 in mid-2024 during a volatile market period.
Analysts had expected stronger results, but Beiersdorf's weak guidance sent shares spiralling. The company now faces pressure from rising raw material costs and sluggish demand in emerging markets. These challenges are squeezing its operating EBIT margin, which is set to dip below last year's 14.0 percent. Despite the downturn, some technical signals suggest a possible rebound. The stock has formed an outside reversal pattern, and the relative strength index indicates oversold conditions. Support levels currently sit at €77. However, short-term liquidity could tighten further due to increased ESG investments and higher marketing spending. Over the long term, Beiersdorf has maintained strong free cash flow. This has allowed the company to fund dividends and share buybacks, even as its stock struggles.
The sharp drop in Beiersdorf's share price reflects investor concerns over weak earnings and rising costs. With the stock trading near €78, analysts are watching for signs of stabilisation. The company's ability to manage inflation and market challenges will determine its recovery path in the coming months.
Read also:
- Federal Funding Supports Increase in Family Medicine Residency Program, Focusing on Rural Health Developments
- Potential Role of DHA in Shielding the Brain from Saturated Fats?
- Alternative Gentle Retinoid: Exploring Bakuchiol Salicylate for Sensitive Skin
- Hanoi initiates a trial program for rabies control, along with efforts to facilitate the transition from the dog and cat meat trade industry.
